["Immune checkpoint inhibitors: what to remember"]

[Article in French]

Affiliations

[Article in French]

Yvon Lebranchu. Rev Prat. 2021 Apr.

. 2021 Apr;71(4):411-412.

¹ Professeur émérite d'immunologie à l'université de Tours, Tours, FranceMembre de l'Académie nationale de médecine.

No abstract available

Keywords: Immunotherapy.

Conflict of interest statement

"L'auteur déclare n’avoir aucun lien d’intérêts."

Immune checkpoint inhibitors in cancer immunotherapy.
Himmel ME, Saibil SD, Saltman AP. Himmel ME, et al. CMAJ. 2020 Jun 15;192(24):E651. doi: 10.1503/cmaj.191231. CMAJ. 2020. PMID: 32540906 Free PMC article. No abstract available.
["Immune checkpoint inhibitors: a paradigm shift"].
Lebranchu Y. Lebranchu Y. Rev Prat. 2021 Apr;71(4):371-373. Rev Prat. 2021. PMID: 34161000 French. No abstract available.
["Immune checkpoint inhibitors in oncology"].
Daëron M, Vivier É. Daëron M, et al. Rev Prat. 2021 Apr;71(4):374-379. Rev Prat. 2021. PMID: 34161001 French.
Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
Qi J, Jin F, Xu X, Du Y. Qi J, et al. Int J Nanomedicine. 2021 Feb 22;16:1435-1456. doi: 10.2147/IJN.S285999. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33654395 Free PMC article. Review.
Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?
Hussain N, Naeem M, Pinato DJ. Hussain N, et al. Hum Vaccin Immunother. 2021 Jan 2;17(1):55-61. doi: 10.1080/21645515.2020.1769398. Epub 2020 Jun 23. Hum Vaccin Immunother. 2021. PMID: 32574106 Free PMC article. Review.